Clinical Trials Logo

Stage IV Ovarian Cancer AJCC v8 clinical trials

View clinical trials related to Stage IV Ovarian Cancer AJCC v8.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04067960 Completed - Clinical trials for Malignant Solid Neoplasm

Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer

Start date: June 6, 2019
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well a genetic test called pharmacogenomics works in directing the optimal use of supportive care medications in patients with stage III-IV cancer. Pharmacogenomics is the study of how genes may affect the body's response to and interaction with some prescription medications. Genes, which are inherited from parents, carry information that determines things such as eye color and blood type. Genes can also influence how patients process and respond to medications. Depending on the genetic makeup, some medications may work faster or slower or produce more or fewer side effects. Pharmacogenomics testing may help doctors learn more about how patients break down and process specific medications based on their genes and improve the quality of life of cancer patients receiving clinical care.

NCT ID: NCT03784677 Completed - Clinical trials for Advanced Malignant Solid Neoplasm

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Start date: July 29, 2019
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of SOR-C13 in treating patients with solid tumors that have spread to other places in the body (advanced) and does not respond to treatment. Drugs used in chemotherapy, such as SOR-C13, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.